Kathy Collins is an Investor at Boehringer Ingelheim, whose known portfolio counts 9 companies.
Is Kathy Collins a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Investor at Boehringer Ingelheim, whose known portfolio counts 9 companies
- Otto
- Ilara Health
- Promethera Biosciences
- Click Therapeutics
- MabVax Therapeutics
- NBE-Therapeutics
- Yale Cancer Center
- Greybox Solutions
- Proxygen
Investor Profile
Founders in the listed sectors AI and Healthcare, and focus areas AI Applications, Animal Health, Biotech and Digital Health fall inside that listing.
Boehringer Ingelheim appears in Growth, Late-Stage and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Kathy Collins is worth approaching.
Colleagues at Boehringer Ingelheim
Detlev Mennerich
Global Head of Boehringer Ingelheim Venture Fund (BIVF)
Bad Kreuznach, Germany
Sebastian Kreuz
Head of Boehringer Ingelheim Venture Fund EU
Ingelheim am Rhein, Germany
Javier Rozada
Sr. Manager Venture Fund en Boehringer Ingelheim
Frankfurt, Germany
Michael Schorpp
Investor
Biberach an der Riß, Germany
Oliver Reuss
Executive Director / Investment Manager
Germany
Steve Boren
Investor
Duluth, United States
Bijon Duran
Group Leader
St Joseph, United States
Yifang Cui
Investment Director
Germany
Mia Hu
Investment Senior Director
Hong Kong
Diogo António Semedo Amaro
Investor
Lagoa, Portugal
Frequently asked questions
Who is Kathy Collins?
Kathy Collins is a corporate venture investor based in Ridgefield, Connecticut, United States, listed as Investor at Boehringer Ingelheim. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Kathy Collins personally.
What does Kathy Collins invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Animal Health, Biotech and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kathy Collins invest at?
Boehringer Ingelheim appears in Growth, Late-Stage and Series A rounds across its known deals, and Kathy Collins is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kathy Collins listed at?
Kathy Collins is listed as Investor at Boehringer Ingelheim. 10 other people in the database share a firm with Kathy Collins.
How do I contact Kathy Collins?
A LinkedIn page is on file for Kathy Collins. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal